D. C. Portnoy | Charles Explorer

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study

2019 | Publikace bez příslušnosti k fakultě